Research / SINT / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-23-027190 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
21.06% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
19.29% · OPTIONAL · VALID
Operating cash generation 91th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-629.92% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
111.67% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 36th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
173.82% · OPTIONAL · VALID
Gross margin 91th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
79.53% · CORE · VALID
Operating margin 82th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
-681.89% · CORE · VALID
R&D intensity 27th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
422.83% · OPTIONAL · VALID
SBC intensity 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
13.98% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 7/9 normalized Level 3 Jun 30, 2023 7/9 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 27.83%
Current 21.06%
Delta -6.77% Capex Intensity Decreased
Previous 43.78%
Current 19.29%
Delta -24.49% Cash Generation Increased
Previous -903.71%
Current -629.92%
Delta 273.79% Growth Decreased
Previous 317.83%
Current 111.67%
Delta -206.16% Inventory Pressure Increased
Previous 116.14%
Current 173.82%
Delta 57.68% Margin Increased
Previous 78.11%
Current 79.53%
Delta 1.42% Profitability Decreased
Previous -659.93%
Current -681.89%
Delta -21.96% R And D Intensity Increased
Previous 408.16%
Current 422.83%
Delta 14.67% Sbc Intensity Decreased
Previous 15.96%
Current 13.98%
Delta -1.98% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.